01.03.2011 • NewsDow ChemicalCitigroupPeople

Andrew Liveris To Leave Citi Board

Dow Chemicals Andrew Liveris will not stand for re-election Citibanks annual...
Dow Chemical's Andrew Liveris will not stand for re-election Citibank's annual meeting on April 21.

Dow Chemical Chief Executive Andrew Liveris will leave Citigroup board of directors in April, the bank said in a regulatory filing on Monday. Liveris will not stand for re-election at the bank's annual meeting on April 21, according to the filing.

The head of the largest U.S. chemical maker, Liveris joined Citigroup's board in 2005 and was one of the few remaining directors from before the financial crisis. He is also on the IBM board of directors.

Regulators pressed the bank to add more directors with financial experience during the crisis, as massive losses forced Citigroup to take $45 billion in U.S. bailout funds. Last month, the bank reported its first full-year profit since 2007.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.